- Downloads: 1.4+ million
- Monthly Active Users: 160,000
- Sales of over 17,000 Wink Thermometers, accounting for over $1.7 million in revenue
- 1.4 million app downloads since inception
- Over 85,000 Daily Sessions
- 53 million days of collected data
- Average of 25,000 new downloads monthly in 2016
- Total Amount Raised: US $691,047
- Total Round Size: US $3,500,000
- Series A :
- Minimum Investment: US $1,000 per investor
- : Preferred Equity
- US $8,000,000 :
Based in Boulder, Colorado, Kindara has been at the forefront of the Femtech revolution since its inception in 2011. Founded out of one couple’s desire to better understand their fertility, we have grown to create:
● A powerful and trusted fertility app
● A robust, growing user community
● The only Bluetooth-connected Basal Body Temperature (BBT) thermometer on the market that connects with our award winning app
As a female focused company, our mission is to provide women the interconnected tools, knowledge, and support to understand how their fertility works, take ownership of their reproductive health, and meet their fertility goals.
Tune-in on Thursday, November 9th at 9:00am ET to see Kindara pitch live to a group of East Coast investors.
Registration URL: https://attendee.gotowebinar.com/register/2932007570419631106
Webinar ID: 626-585-291
For women either trying to conceive (TTC) or trying to avoid conception (TTA), understanding and managing their cycle has historically been a little discussed topic, and often is met with dismissive comments like “just relax.”
Although Fertility Awareness Based Methods (FABMs), which use key indicators like Basal Body Temperature (BBT) and Cervical Fluid Viscosity, have been around for decades to help women understand when they are most and least fertile, they have generally been used by a small number of women with the support of small communities. Yet women who use FABMs achieve pregnancy 5 to 7 times faster than the average couple that only has a 4.7% chance of conceiving when having intercourse on one arbitrarily selected date (as published in the British Medical Journal, Journal of Reproductive Medicine and New England Journal of Medicine).
The Kindara App helps make the process of Fertility Awareness charting easy with simple, intuitive menus and guidance. We also provide a large, non-judgmental community where women can discuss what they are going through in a semi-anonymous environment. Kindara's knowledgeable and supportive community of like-minded women creates a familiar and supportive environment, which is especially important if women are either struggling with infertility or are simply looking for initial guidance from a peer versus a physician.
The size and passion of the Kindara community gives us the opportunity to add a “Freemium” model, adding exciting new features in exchange for a modest monthly subscription fee. The trusted Kindara Fertility App, downloaded over 1.4 million times and being used more than twice a day on average with over 85K daily sessions, has been updated to include new features, including Kindara Premium; a subscription-based platform within the Kindara App that offers community members more data fields, customization and greater access to develop public and private community groups to continue to grow the support system of the over 75,000 monthly comments received.
In speaking with users who participate in multiple Kindara communities that have emerged on Facebook, many have expressed interest in bringing those communities to a Kindara platform that allows them to keep their anonymity, yet still cultivate the relationships they have forged - from trying to conceive to pregnancy and birth.
By employing this Freemium model, we will enable additional integrated fertility products and services with our app while growing the scale and vibrancy of our community.
With two design patents and one pending utility patent, the Kindara Wink, which pairs specifically with the Kindara App, has generated more than 1.7 million dollars in revenue for the brand, 17,000 units sold and over 150,000 reported pregnancies. The innovation of the Wink is unique as it goes far beyond a classic thermometer’s capabilities and provides women the proper tools to seamlessly track important fertility data. Using key feedback from Kindara’s Community, Wink was designed to ease the charting process by taking unnecessary factors out of the temperature taking equation, making charting quick, easy and accurate by automatically feeding BBT into the app via Bluetooth.
Some of these unique innovations include:
- Vibrations alert the user that the data has been tracked, doing away with the beeping noises of traditional thermometers that kept women from taking their temperature first thing in the morning as to avoid waking their partner
- Automatically syncing data to a Bluetooth synced device and storing 30 temperature entries to avoid women forgetting to write down the number, falling back asleep before charting the data or failing to remember the number correctly
- Tip shape that is flexible and slim for both user comfort and data accuracy
- A revolutionary high-sensitivity thermistor and and new algorithm enable Wink to take a temperature faster than traditional thermometers (20 seconds)
In 2018, we will launch the next generation Wink model with the same functionality, expanding distribution through new product development that lowers COGs to enable a mass market pricing model for retail and healthcare channels.
With the strength of both our scaled community and strong app platform, Kindara will also integrate new trusted connected devices that will help women achieve their fertility goals, giving them choice along their fertility journey.
With such a large and engaged community with highly defined fertility goals, Kindara has a tremendous opportunity to provide additional value added services. We are focused on two opportunities: DNA and education services.
We recently announced a partnership with Helix, a personal genomics company creating a marketplace for DNA powered products, in which we are developing Kindara DNA for launch in 2018. Kindara DNA will be the first at home DNA test designed specifically to sync with a trusted fertility app, integrating nutrition, fitness, wellness and fertility genomic data to provide industry leading personalization of women’s health at every stage from puberty to fertility.
For Kindara users seeking expanded Natural Family Planning (NFP) educational services, we have partnered with SymptoPro’s network of highly experienced and trained fertility education instructors to develop the Kindara Fertility Coaching product. This service will take the guesswork out of Fertility Awareness Based Methods (FABMs), utilizing personalized one-on-one professional education and coaching for women looking to help make sense of their charts and further their understanding of FABMs.
Data is another major opportunity for Kindara. With over 4 million new data points a month, Kindara can leverage fully anonymized and de-identified data to dive deeper into analytics to help more women meet their fertility goals. To this end, Kindara recently announced a collaboration with Ecole Polytechnique Fédérale de Lausanne (EPFL) Digital Epidemiology – Global Health Institute – Life Science Faculty out of Switzerland. The study aims at using de-identified and anonymized data to compare cycles, identify patterns and detect variations that could indicate medical conditions such as Polycystic Ovary Syndrome (PCOS).
Kindara’s platform provides endless opportunities to expand revenue and offer products and services that align with the fertility goals of our audience.
Kindara was founded with one simple goal: give women the tools they need to manage their reproductive health. Will Sacks and Kati Bicknell founded Kindara in 2011, and remain on the board of directors and as advisors. In 2016, Kindara started building a seasoned management team to take the company to the next level.
The graph below illustrates theor the of Kindara Inc.'s prior rounds by year.
Kindara has 3 current and developing revenue streams:
Revenue associated with sales of connected devices like our Wink Basal Body Temperature thermometer.
- These sales come primarily from direct sales through Kindara.com, as well as sales through our relationship with Amazon.com.
- We are currently developing products that could offer the ability to expand distribution to traditional retail, which could result in increased penetration of our app. We do not expect these products to launch until 2018.
Revenue from the Kindara app, notably in the form of recurring revenue from subscriptions, which will offer users expanded services and features.
- We expect this to launch in Q3 of 2017, with revenue starting in Q4 2017.
Revenue from partnerships with companies that have goods and services we believe are desirable to our users.
- These partnerships could also include connected counseling, sales of products, etc.
Within the $200 billion Femtech category, the target market for Kindara is twofold:
● TTC (trying to conceive) population of women, +6M pregnant women per annum, a $21.6B global fertility business by 2020
● TTA (trying to avoid) population of women, 23.9% percent of women aged 15-44 who use hormonal contraceptives (pill and IUD), $1,000 individual annual average out of pocket cost of birth control
With the average cost of an IVF cycle at $23,000 (and insurance covering a smaller percentage of these interventions), more and more women are looking to methods that help pinpoint their ovulation to achieve pregnancy sooner as well as help to identify infertility issues earlier. Additionally, as young women continue to question long term impacts to their fertility using hormonal birth control methods, Natural Family Planning have seen a recent 17% increase in adoption from 2002 to 2010 (source: CDC).
Our direct competition are apps like Glow, Clue, and Ovia Health that provide fertility tracking services similar to Kindara. We also view standard BBT thermometers as our competition on the device side of our business, Wink.
• Glow: An ovulation calculator, period tracker, and fertility calendar to help women take control of their reproductive health
• Clue: An app built on machine learning to track a woman’s monthly menstrual cycle
• Ovia Health: A fertility, pregnancy, and parenting platform, the Ovia app family includes specific apps for each of the following: fertility, pregnancy, and parenting
We believe that, in comparison to our competition listed above, Kindara’s advantage is:
1. A path to meaningful revenue (in terms of leading to potential liquidity events) and profitability by the end of 2018, with one focus: continued increase in premium app downloads that lead to revenue in three areas:
a. Subscription Revenue
b. Connected Devices
c. Additional Products and Services
2. Kindara’s point of differentiation: Our community that drives a platform of connected and integrated products & services
3. We believe we can be the first Femtech to sustainable revenue and profitability with a relentless focus on executing against the strategic initiatives laid out
Start-up investing is risky. Investing in startups is very risky, highly speculative, and should not be made by anyone who cannot afford to lose their entire investment. Unlike an investment in a mature business where there is a track record of revenue and income, the success of a startup or early-stage venture often relies on the development of a new product or service that may or may not find a market. Before investing, you should carefully consider the specific risks and disclosures related to both this offering type and the company which can be found in this company profile and the documents in the data room below.
Your shares are not easily transferable. You should not plan on being able to readily transfer and/or resell your security. Currently there is no market or liquidity for these shares and the company does not have any plans to list these shares on an exchange or other secondary market. At some point the company may choose to do so, but until then you should plan to hold your investment for a significant period of time before a “liquidation event” occurs. A “liquidation event” is when the company either lists their shares on an exchange, is acquired, or goes bankrupt.
The Company may not pay dividends for the foreseeable future. Unless otherwise specified in the offering documents and subject to state law, you are not entitled to receive any dividends on your interest in the Company. Accordingly, any potential investor who anticipates the need for current dividends or income from an investment should not purchase any of the securities offered on the Site.
Valuation and capitalization. Unlike listed companies that are valued publicly through market-driven stock prices, the valuation of private companies, especially startups, is difficult to assess and you may risk overpaying for your investment. In addition, there may be additional classes of equity with rights that are superior to the class of equity being sold.
You may only receive limited disclosure. While the company must disclose certain information, since the company is at an early-stage they may only be able to provide limited information about its business plan and operations because it does not have fully developed operations or a long history. The company may also only obligated to file information periodically regarding its business, including financial statements. A publicly listed company, in contrast, is required to file annual and quarterly reports and promptly disclose certain events — through continuing disclosure that you can use to evaluate the status of your investment.
Investment in personnel. An early-stage investment is also an investment in the entrepreneur or management of the company. Being able to execute on the business plan is often an important factor in whether the business is viable and successful. You should be aware that a portion of your investment may fund the compensation of the company’s employees, including its management. You should carefully review any disclosure regarding the company’s use of proceeds.
Possibility of fraud. In light of the relative ease with which early-stage companies can raise funds, it may be the case that certain opportunities turn out to be money-losing fraudulent schemes. As with other investments, there is no guarantee that investments will be immune from fraud.
Lack of professional guidance. Many successful companies partially attribute their early success to the guidance of professional early-stage investors (e.g., angel investors and venture capital firms). These investors often negotiate for seats on the company’s board of directors and play an important role through their resources, contacts and experience in assisting early-stage companies in executing on their business plans. An early-stage company may not have the benefit of such professional investors.
Frequently Asked Questions
"The SEC has qualified this offering" means the SEC has permitted Kindara Inc. to offer for sale the securities described in the Offering Circular to investors such as you. The SEC is not judging the merits, accuracy, or completeness of the offering and information in the Offering Circular. Rather, the SEC is merely ensuring Kindara Inc. has met all legal disclosure and regulatory requirements necessary to make these shares available to you.
When you complete your investment on SeedInvest, your money will be transferred to an escrow account where an independent escrow agent will watch over your investment until it is accepted by Kindara Inc.. Once Kindara Inc. accepts your investment, and certain regulatory procedures are completed, your money will be transferred from the escrow account to Kindara Inc. in exchange for your shares. At that point, you will be a proud owner in Kindara Inc..
Preferred equity is usually issued to outside investors and carries rights and conditions that are different from that of common stock. For example, preferred equity may include rights that prevent or minimize the effects of dilution or grants special privileges in situations when the company is sold.
A convertible note is a unique form of debt that converts into equity, usually in conjunction with a future financing round. The investor effectively loans money to a startup with the expectation that they will receive equity in the company in the future at a discounted price per share when the company raises its next round of financing.
To learn more about startup investment types check out “How to Choose a Startup Investment” in our academy.
To make an investment, you will need the following information readily available:
- Personal information such as your current address and phone number
- Employment and employer information
- Net worth and income information
- Social Security Number or government-issued identification
- ABA bank routing number and checking account number (typically found on a personal check or bank statement)
Until a closing occurs, you may cancel your investment at any time, for any reason. You will receive an email when the closing occurs and your shares have been issued. If you have already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To cancel your investment, please go to your portfolio page.
Currently there is no market or liquidity for these shares. Right now Kindara Inc. does not plan to list these shares on a national exchange or another secondary market. At some point Kindara Inc. may choose to do so, but until then you should plan to hold your investment for a significant period of time before a “liquidation event” occurs. A “liquidation event” is when Kindara Inc. either lists their shares on an exchange, is acquired, or goes bankrupt.
You can return to SeedInvest at any time to view your portfolio of investments and obtain a summary statement.
This is Kindara Inc.'s fundraising profile page, where you can find information that may be helpful for you to make an investment decision in their company. The information on this page includes the company overview, team bios, and the risks and disclosures related to this investment opportunity. You will also find a copy of the Kindara Inc.'s Offering Circular, which has been qualified by the SEC. The Offering Circular includes important details about Kindara Inc.'s fundraise that you should review before investing.
This investment is highly speculative and should not be made by anyone who cannot afford to risk the entire investment amount. In addition to these risks, you should carefully consider the specific information and risks disclosed in Kindara Inc.’s profile and Offering Circular.